作为中国益生菌行业的先行者，均瑶集团旗下的均瑶健康在益生菌领域实现了从菌种筛选到产品终端的全流程数字化应用。自2006年起，均瑶健康便建立了 菌株库，通过数字化技术将菌种储备从最初的4000多种快速扩充至4万多种。 据王均豪介绍，过去，企业获取到大自然、人体、植物中的菌种，需要通过不断试验才能鉴别菌种对人体是否有益，但如今借助数字化手段，已经可以快速 分辨菌种类别。 "在菌株筛选过程中，我们采用数字化技术快速高效鉴别菌种是否有益，并在此基础上通过科学方法进一步筛选出具有特定功能优势的菌株。例如，我们与 如皋开展战略合作，从百岁老人体内成功分离出上万株优质菌株，充分展现了数字技术带来的研发效率革命。"王均豪进一步解释。 "企业需要数字化，也必须拥抱数字化。"均瑶集团党委书记、总裁，均瑶健康董事长王均豪在由《中国经营报》主办的"破浪·共生——2025中国数字产业生 态大会"上如是表示。 "数字化转型"作为全球经济共同作答的时代必答题，深刻重塑着企业的生存逻辑、产业的竞争格局。关于传统企业该如何找准数字化转型的路径，实现破局 生长，王均豪带来了以《全球数字化转型：均瑶集团的技术愿景与实践》为主题的演讲，并分享了均瑶 ...

Core Viewpoint - The article discusses the impact of the Trump administration's tariff policies on Canada and its subsequent shift in focus towards China, highlighting the complexities and contradictions in Canada's trade policies and its reliance on the U.S. market [1][5][7]. Group 1: Tariff Policies and Economic Impact - The Trump administration imposed a 50% tariff on steel and aluminum imports, significantly affecting Canada as the largest importer of these materials from the U.S. [1] - In 2022, nearly half of Canada's steel imports came from the U.S., while 91% of its steel exports were sent to the U.S., indicating a high dependency on the American market [1][3]. - Canada is preparing to impose a 35% tariff on U.S. imports after August 1, reflecting its struggle to negotiate the removal of tariffs with the U.S. [1][3]. Group 2: Canada's Response to China - The Canadian government, led by Carney, plans to impose a 50% tariff on steel exports from countries without a free trade agreement with Canada, including China, if their export levels exceed 2024 figures [3]. - Additionally, a 25% tariff will be applied to all steel products from countries outside the U.S., including China, due to concerns over potential surges in cheap steel imports [3]. - Carney's rationale for these tariffs is based on fears of Chinese steel flooding the Canadian market due to U.S. tariffs, although this reasoning has been criticized as a misrepresentation of the "overcapacity" narrative [3][5]. Group 3: Contradictions in Trade Policy - Canada's trade policy appears contradictory, as it criticizes "Chinese manufacturing" while benefiting from trade with China, such as in the case of a British Columbia ferry company purchasing vessels from Chinese manufacturers [5][7]. - The Canadian government faces internal conflicts regarding support for domestic industries versus engaging in trade with China, highlighting the complexities of its trade relationships [5][7]. - The article emphasizes that Canada should reconsider its reliance on the U.S. and seek diversified partnerships rather than escalating tensions with China [5][8].

Group 1 - The core viewpoint of the news is the significant achievements of the Tianjin Free Trade Zone (FTZ) over the past ten years, highlighting its role in promoting institutional innovation and economic growth [1][2] - Since its establishment in April 2015, the Tianjin FTZ has implemented 686 institutional innovation measures, with 49 of these measures replicated nationwide, accounting for 14.2% of the total nationwide replication [1] - The FTZ hosts nearly 90,000 market entities, utilizing only 1% of Tianjin's land while contributing 26% of new foreign investment enterprises, 38% of imports and exports, 43% of actual foreign capital utilization, and 16% of tax revenue in the city [1] Group 2 - The Tianjin FTZ has adopted a strategy of innovative and differentiated reforms to stimulate market vitality and has successfully created leading industrial clusters that contribute to high-quality development [2][3] - Financial innovation has been a key focus, with over 40 leasing models explored, and the FTZ accounts for over 70% of the national cross-border leasing business in sectors like aircraft and ships [2] - The "bonded +" model has flourished, with bonded maintenance services covering various industries and the introduction of bonded research and development in the aviation sector [3] Group 3 - The development of network freight has been robust, integrating 4.266 million drivers and 3.925 million vehicles, with a projected completion of 53.67 million orders and a freight volume of 580 million tons in 2024, generating over 90 billion yuan in total freight charges [3] - The biopharmaceutical sector has seen significant breakthroughs, attracting over 200 key enterprises and achieving a production value of nearly 50 billion yuan through innovative policies and regulations [3] - The People's Bank of China in Tianjin has implemented over 50 high-impact innovative policies, benefiting 90,000 business entities and facilitating cross-border transactions totaling 430 billion USD and 870 billion yuan [4][5]